A new Strategic Research Centre (SRC) funded by the Cystic Fibrosis Trust will be investigating joint disease in the cystic fibrosis community. Joint pain and disease affect more than 1 in 10 people living with CF, but there is currently no CF-related diagnosis or treatment method in place.
The main aims of the project will be developing a method for identifying cystic fibrosis-related arthropathy (CFA), researching therapeutic treatments, and understanding the use of ultrasound in identifying joint inflammation. Most importantly, this centre will be investigating the link between joint inflammation and inflammation of the lungs in people with cystic fibrosis. Determining the link between joints and lungs will help researchers to determine whether drugs that reduce general inflammation could be used to reduce lung inflammation.
This exciting new research centre will be led by Professor Michael McDermott from the Leeds Institute of Rheumatic and Musculoskeletal Medicine, and he will be joined by researchers from across the UK and Switzerland. This centre will receive £750,000 of Trust funding, and will run for three to four years. Find out more and watch our brand new SRC video!
Take a look at the other research we are funding.
Each Strategic Research Centre costs approximately £750,000 over three or four years - donate now to support more vital research like this.